RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Squamous Cell Carcinoma - Pipeline Review, Q4 2010
Dec 2010 - 27 pages - $500
Squamous Cell Carcinoma Global Clinical Trials Review, Q4, 2010
Dec 2010 - 73 pages - $1,000
Squamous Cell Carcinoma - Pipeline Review, H2 2011
Aug 2011 - 236 pages - $500
Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy
Feb 2011 - 6 pages - $500
Renal Cell Carcinoma - Pipeline Review, Q3 2011
Jul 2011 - 390 pages - $500
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Basal Cell Carcinoma - Pipeline Review, Q2 2011
Jun 2011 - 58 pages - $500
Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report
Nov 2010 - 324 pages - $1,495
Renal Cell Carcimona Drug Discoveries - what the future holds
Feb 2010 - 138 pages - $2,265
Squamous Cell Carcinoma - Pipeline Review, Q2 2011
Apr 2011 - 226 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Oncology del
Stomach/Esophageal del
Squamous cell carcinoma del
Development phase
Phase III/IV del

Browse By

Industry sector
Generics
Nutrition
OTC/Non-Prescription
Pediatric
Personal Care
Prescription

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us